Ascent helps with saving
July 28, 2011
ASCENT Pharmaceuticals says
a new exclusive distribution
agreement with GlaxoSmithKline
will help pharmacists boost
margins in the current tough
economic environment.
The deal will see Ascent
promote and distribute sixteen
of GSK’s classic brands via the
Ascent PharmAnnuity program
and the CHS distribution
network.
The brands covered by the
new pact include Ventolin,
Lamictal and Augmentin, and
have a total estimated PBS
value of $95 million.
Ascent already has
PharmAnnuity distribution
agreements in place with MSD
and Pfizer, and these, together
with its latest deal are
claimed to to help pharmacists
“offset some of the losses
caused by PBS reform”.
“In the past 12 months alone
we have delivered over $3
million worth of savings on
brands back to pharmacy,
through the PharmAnnuity
program,” said General
Manager Sales for Ascent
Pharmaceuticals, Andrew Heine.
“We look forward to offering
pharmacists the opportunity to
increase their profits even
further through this association
with GSK,” he added.
GSK Pharmaceuticals Australia
gm, Deborah Waterhouse, said
the company had enjoyed
strong relationships with
pharmacists over many years
“and we are always looking for
opportunities to do more.”
The GSK Ascent PharmAnnuity
offer kicked off this month.
The above article was sent to subscribers in Pharmacy Daily's issue from 28 Jul 11To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 28 Jul 11
